Navigation Links
Bioponic Phytoceuticals Announces Record Sales Increase of 40% for the Month of January
Date:2/7/2008

MAUI, Hawaii, Feb. 7 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT) today announced that sales for the month of January 2008 increased 40% compared to sales for the month of January 2007.

"We achieved a record breaking month of sales in January, primarily from continued success of our Flight Spray product. We are also gaining market traction for our latest product release, an all-natural solution for baby care marketed under the Gentle Mother(TM) line," said Steven M. Schorr, Chairman & CEO of Bioponic. "Bioponic is now focused on establishing distribution relationships that will greatly expand the availability of multiple product lines, including O-Spray(TM), Throat Note(TM), Gentle Mother(TM), Hawaiian Healing Mist, and Noni Healing Tonic for placement into national health food stores and natural products retailers. Our goal is take our core product lines and position them for exponential sales growth, much like Flight Spray achieved when it gained a presence in over 1,000 points of distribution."

"We have secured an agreement with a leading wholesaler-distributor in the Natural Food industry to bring five of our all natural health and wellness product lines, representing 11 products, into 1,000 retail stores in the Western U.S. We expect the results of this distributorship, and other marketing channels, will lead to aggressive total revenue growth for Bioponic in 2008," said Schorr.

About Bioponic Phytoceuticals

Bioponic Phytoceuticals is engaged in the formulation, production and distribution of natural products for sale in the Complementary Alternative Medicine markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics(TM)" and has several branded product lines currently in national distribution. For further information, please see http://www.bioponic.com.

All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company's control.

CONTACT: Steven M. Schorr, CEO, Bioponic Phytoceuticals, +1-808-876-1711, info@bioponic.com or Geoffrey Eiten, Investor Relations, OTC Financial Network, +1-781-444-6100x613, geiten@otcfn.com, http://www.otcfn.com/bpyt.


'/>"/>
SOURCE Bioponic Phytoceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Bioponic Phytoceuticals to Roll Out Multiple Products to 1,000 Major Health Food Stores in the Western United States
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
4. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
7. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Calif. , Jan. 19, 2017  ArmaGen, ... Mathias Schmidt , Ph.D., as chief executive officer, ... of directors. Dr. Schmidt brings to ArmaGen more than ... the research and development of biotherapeutics and pharmaceuticals. ... executive with the diverse experience and skillset necessary ...
(Date:1/19/2017)... ... January 18, 2017 , ... LabRoots , ... from around the world, was today awarded the "Best Science & Technology Social ... on merit and decided upon by a dedicated team of researchers and analysts. ...
(Date:1/19/2017)... , Jan. 18, 2017 The ... reach USD 92.9 billion by 2025, according to ... Pharmaceutical industry has been adaptive of the function ... early as 2002. Among the services outsourced, clinical ... For instance, Johnson & Johnson was the first ...
(Date:1/19/2017)... FRANKLIN LAKES, N.J. , Jan. 18, 2017 BD ... medical technology company, announced today that it will host a live ... 2017, at 1 p.m. (ET). The webcast can ... will be available for replay through Tuesday, January 31, 2017. ... About BD ...
Breaking Biology Technology:
(Date:1/18/2017)... 2017 MedNet Solutions , an ... entire spectrum of clinical research, is proud to ... for the organization in terms of corporate growth, ... products and services. The company,s exceptional achievements can ... iMedNet ™ – ...
(Date:1/12/2017)... , Jan. 12, 2017  New research undertaken by ... of the future.  1,000 participants were simply asked which office ... which we may consider standard issue.  Insights on what ... were also gathered from futurists and industry leaders including ... James Canton .  Some of these ...
(Date:1/11/2017)... NEW BRUNSWICK, N.J. , Jan. 11, 2017  Michael Johnson, ... from Foundation Venture Capital Group, Inc., has been named to the ... Johnson, 27,  was one of 600 people in 20 fields ... only four percent of the 15,000 applicants were selected. ... He is currently a PhD ...
Breaking Biology News(10 mins):